These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18701910)

  • 41. Adeno-associated virus site-specific integration and AAVS1 disruption.
    Hamilton H; Gomos J; Berns KI; Falck-Pedersen E
    J Virol; 2004 Aug; 78(15):7874-82. PubMed ID: 15254160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.
    Nathwani AC; Davidoff A; Hanawa H; Zhou JF; Vanin EF; Nienhuis AW
    Blood; 2001 Mar; 97(5):1258-65. PubMed ID: 11222368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Next-generation AAV vectors-do not judge a virus (only) by its cover.
    Domenger C; Grimm D
    Hum Mol Genet; 2019 Oct; 28(R1):R3-R14. PubMed ID: 31261383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promoter CAG is more efficient than hepatocyte‑targeting TBG for transgene expression via rAAV8 in liver tissues.
    Kang J; Huang L; Zheng W; Luo J; Zhang X; Song Y; Liu A
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34779500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein.
    Kyöstiö SR; Wonderling RS; Owens RA
    J Virol; 1995 Nov; 69(11):6787-96. PubMed ID: 7474090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.
    Kurpad C; Mukherjee P; Wang XS; Ponnazhagan S; Li L; Yoder MC; Srivastava A
    J Hematother Stem Cell Res; 1999 Dec; 8(6):585-92. PubMed ID: 10645765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
    Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
    J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of alpha-galactosidase A and the induction of immune tolerance in Fabry mice.
    Ziegler RJ; Lonning SM; Armentano D; Li C; Souza DW; Cherry M; Ford C; Barbon CM; Desnick RJ; Gao G; Wilson JM; Peluso R; Godwin S; Carter BJ; Gregory RJ; Wadsworth SC; Cheng SH
    Mol Ther; 2004 Feb; 9(2):231-40. PubMed ID: 14759807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
    Lieber A; Steinwaerder DS; Carlson CA; Kay MA
    J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuraminidase-mediated desialylation augments AAV9-mediated gene expression in skeletal muscle.
    Zhu H; Wang T; John Lye R; French BA; Annex BH
    J Gene Med; 2018 Sep; 20(9):e3049. PubMed ID: 30101537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
    Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
    Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
    Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
    J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of liver-specific enhancer-promoter activity in the 3' untranslated region of the wild-type AAV2 genome.
    Logan GJ; Dane AP; Hallwirth CV; Smyth CM; Wilkie EE; Amaya AK; Zhu E; Khandekar N; Ginn SL; Liao SHY; Cunningham SC; Sasaki N; Cabanes-Creus M; Tam PPL; Russell DW; Lisowski L; Alexander IE
    Nat Genet; 2017 Aug; 49(8):1267-1273. PubMed ID: 28628105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
    Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
    Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AAV
    Xiong W; Wu DM; Xue Y; Wang SK; Chung MJ; Ji X; Rana P; Zhao SR; Mai S; Cepko CL
    Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5785-5794. PubMed ID: 30833387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glial fibrillary acidic protein promoter determines transgene expression in satellite glial cells following intraganglionic adeno-associated virus delivery in adult rats.
    Xiang H; Xu H; Fan F; Shin SM; Hogan QH; Yu H
    J Neurosci Res; 2018 Mar; 96(3):436-448. PubMed ID: 28941260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective transgene expression in cerebellar Purkinje cells and granule cells using adeno-associated viruses together with specific promoters.
    Kim Y; Kim T; Rhee JK; Lee D; Tanaka-Yamamoto K; Yamamoto Y
    Brain Res; 2015 Sep; 1620():1-16. PubMed ID: 25988836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-Throughput
    Westhaus A; Cabanes-Creus M; Rybicki A; Baltazar G; Navarro RG; Zhu E; Drouyer M; Knight M; Albu RF; Ng BH; Kalajdzic P; Kwiatek M; Hsu K; Santilli G; Gold W; Kramer B; Gonzalez-Cordero A; Thrasher AJ; Alexander IE; Lisowski L
    Hum Gene Ther; 2020 May; 31(9-10):575-589. PubMed ID: 32000541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting transgene to the heart and liver with AAV9 by different promoters.
    Chen BD; He CH; Chen XC; Pan S; Liu F; Ma X; Li XM; Gai MT; Tao J; Ma YT; Yang YN; Gao XM
    Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1108-17. PubMed ID: 26173818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
    Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.